天山生物
(300313)
| 流通市值：25.81亿 | | | 总市值：31.36亿 |
| 流通股本：1.97亿 | | | 总股本：2.40亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 26,175,061.38 | 31,018,511.3 | 39,392,937.53 | 8,739,557.55 |
| 应收票据及应收账款 | 32,484,424.87 | 31,534,807.93 | 21,238,328.41 | 13,179,725.08 |
| 应收账款 | 32,484,424.87 | 31,534,807.93 | 21,238,328.41 | 13,179,725.08 |
| 预付款项 | 2,153,403.85 | 2,634,242.69 | 153,680.18 | 1,259,838.24 |
| 其他应收款合计 | 7,584,552.94 | 8,050,808.54 | 7,240,958.46 | 3,547,213.85 |
| 存货 | 48,134,396.87 | 40,848,293.15 | 33,587,666.47 | 68,340,601.27 |
| 其他流动资产 | 200,829.26 | 492,191.55 | 272,733.09 | 419,800.9 |
| 流动资产合计 | 116,732,669.17 | 114,578,855.16 | 101,886,304.14 | 95,486,736.89 |
| 非流动资产: | | | | |
| 长期股权投资 | 18,059,387.4 | 16,671,577.96 | 15,539,099.41 | 15,838,242.19 |
| 投资性房地产 | 19,878,630.23 | 20,418,030.81 | 21,056,264.81 | 24,819,161.21 |
| 固定资产 | 55,886,128.37 | 57,051,738.44 | 58,196,947.32 | 59,140,012.4 |
| 在建工程 | 7,282,812.65 | 5,990,158.65 | 3,823,645.81 | 1,500,000 |
| 生产性生物资产 | 2,563,089.71 | 2,757,072.12 | 2,816,327.55 | 3,146,405.03 |
| 使用权资产 | 8,764,711.5 | 11,043,265.4 | 8,844,012.71 | 5,224,946.82 |
| 无形资产 | 51,943,879.68 | 52,685,831.97 | 53,415,884.4 | 59,944,674.6 |
| 长期待摊费用 | 3,943,313.84 | 4,789,334.44 | 5,083,197.04 | 4,025,847.6 |
| 递延所得税资产 | 7,604,263.28 | 8,126,714.23 | 7,975,046.72 | 7,412,308.78 |
| 其他非流动资产 | 994,764.19 | 994,764.19 | 994,764.19 | 994,764.19 |
| 非流动资产合计 | 176,920,980.85 | 180,528,488.21 | 177,745,189.96 | 182,046,362.82 |
| 资产总计 | 293,653,650.02 | 295,107,343.37 | 279,631,494.1 | 277,533,099.71 |
| 流动负债: | | | | |
| 短期借款 | - | - | - | 49,480,428.5 |
| 应付票据及应付账款 | 27,016,572.55 | 21,345,892.09 | 16,580,936.85 | 11,767,283.61 |
| 应付账款 | 27,016,572.55 | 21,345,892.09 | 16,580,936.85 | 11,767,283.61 |
| 预收款项 | 8,041,441.18 | 9,172,721.39 | 13,823,066.12 | 4,000,689.26 |
| 合同负债 | 4,986,469.08 | 3,587,615.23 | 4,099,302.22 | 4,835,178.27 |
| 应付职工薪酬 | 3,695,840.68 | 3,802,009.07 | 4,247,792.32 | 2,852,080.7 |
| 应交税费 | 941,046.66 | 1,447,708.67 | 1,381,351.04 | 2,190,381.35 |
| 其他应付款合计 | 12,844,969.69 | 12,670,953.9 | 13,986,988.63 | 15,527,690.43 |
| 一年内到期的非流动负债 | 57,648,073.63 | 43,930,878.58 | 2,084,123.67 | 1,504,046.14 |
| 流动负债合计 | 115,174,413.47 | 95,957,778.93 | 56,203,560.85 | 92,157,778.26 |
| 非流动负债: | | | | |
| 长期借款 | 30,500,000 | 30,600,000 | 30,600,000 | 30,700,000 |
| 租赁负债 | 4,444,383.37 | 5,757,347.44 | 5,356,173.77 | 3,129,291.37 |
| 递延收益 | 19,402,617.89 | 19,547,945.72 | 21,014,749.14 | 15,649,194.48 |
| 递延所得税负债 | 1,383,095.1 | 1,933,663.4 | 1,904,650.12 | 1,306,236.71 |
| 其他非流动负债 | 70,000,000 | 90,000,000 | 120,000,000 | 90,000,000 |
| 非流动负债合计 | 125,730,096.36 | 147,838,956.56 | 178,875,573.03 | 140,784,722.56 |
| 负债合计 | 240,904,509.83 | 243,796,735.49 | 235,079,133.88 | 232,942,500.82 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 239,778,994 | 239,778,994 | 239,778,994 | 312,977,396 |
| 资本公积 | 298,924,081.44 | 297,459,835.66 | 296,525,315.11 | 210,590,113.12 |
| 盈余公积 | 10,813,961.16 | 10,813,961.16 | 10,813,961.16 | 10,813,961.16 |
| 未分配利润 | -511,246,563.2 | -511,312,690.42 | -515,474,233.13 | -499,987,657.67 |
| 归属于母公司股东权益合计 | 38,270,473.4 | 36,740,100.4 | 31,644,037.14 | 34,393,812.61 |
| 少数股东权益 | 14,478,666.79 | 14,570,507.48 | 12,908,323.08 | 10,196,786.28 |
| 股东权益合计 | 52,749,140.19 | 51,310,607.88 | 44,552,360.22 | 44,590,598.89 |
| 负债和股东权益合计 | 293,653,650.02 | 295,107,343.37 | 279,631,494.1 | 277,533,099.71 |
| 公告日期 | 2026-08-29 | 2026-04-25 | 2026-04-25 | 2025-10-25 |
| 审计意见(境内) | | | 带强调事项段的无保留意见 | |